Webinar image

Announcing: Stimulant Use Disorder Webinar Series

Publication Date: May 22, 2019

Sponsored by the Great Lakes ATTC and the Northwest ATTC 
June-August 2019

Stimulant is emerging as a pressing public health problem, overtaking concerns about opioid misuse in some parts of the country. Please join us for this series of three free webinars that cover the critical issues related to stimulant use. 


Webinar 1: Strategies to Address Cocaine and Methamphetamine Use

June 11, 2019
2:00-3:00 PM CDT

This presentation will provide an overview of the current knowledge on the problem of stimulant (cocaine and methamphetamine) use in the US. 

The presentation will provide:

1. A review of the extent and geography of the use of cocaine and methamphetamine.
2. An articulation of the clinical syndromes produced by acute and chronic stimulant use; 3. A description of the strategies for addressing acute intoxication, withdrawal and stimulant induced psychosis;
4. A review of behavioral treatments with evidence of efficacy for the treatment of stimulant use disorders;
5. An overview of the current status of pharmacotherapy research on treatments for stimulant use disorders. A discussion of vulnerable populations, including the problem of stimulant use by individuals in medication treatment for opioid use disorders.

About the presenter:

Richard Rawson is an Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont. He received a Ph.D. in experimental psychology from the University of Vermont in 1974. He has conducted an extensive portfolio of research on cocaine and methamphetamine, including projects on behavioral and medication treatments, with brain imaging measures. He was a member of the Federal Methamphetamine Advisory Group for Attorney General Janet Reno. During the past decade, he has worked with NIDA, SAMHSA, the US State Department, the World Heath Organization and the United Nations Office of Drugs and Crime on international substance abuse research and training projects, exporting US technology and addiction science throughout the world. Dr. Rawson has published 3 books, 40 book chapters and over 240 professional papers and annually conducts numerous workshops, paper presentations and training sessions.


Webinar 2: Treating Individuals with Stimulant Use Disorders

July 18, 2019
2:00-3:00 PM CDT

The second installment of the webinar series will feature a panel of providers presenting their experiences with effective treatment strategies and evidence-based practices for workingwith individuals with stimulant use disorders. 

Section 1: Treating Individuals with Stimulant and Opioid Use Disorders – Evergreen Treatment Center in Seattle, WA.
K. Michelle Peavy, Ph.D., of Evergreen Treatment Services will address challenges and strategies of working with individuals with comorbid opioid use and stimulant use disorders. 

Section 2: Implementing Contingency Management: Lessons Learned from VA’s National Implementation Initiative.
Dominick DePhilippis, Ph.D., will present on use of contingency management in the VA system.

Section 3: Using the MATRIX Model to treat stimulant disorders in a FQHC setting.
Regina Fox will discuss use of the Matrix Model of treatment in a community-based treatment organization. 


Webinar 3: Evidence-Based Practices in Treating Stimulant Use Disorders

Thursday, August 15, 2019 
2:00-3:00 PM CDT

The first two installments of this webinar series focused on effective treatment strategies and models for addressing stimulant use disorders. During this last installment of the webinar series three presenters will discuss change management strategies for successfully implementing these evidence-based practices. 

Todd Molfenter, Ph.D., will provide an overview on how implementation science informs successful uptake of EBPs. 

Bryan Hartzler, PhD., will present tips for community-based implementation of contingency management. 

Denna Vandersloot, M.Ed, will share lessons learned from implementation efforts involving the Matrix Model of treatment